Eyyüp Hakan Uçar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eyyüp Hakan Uçar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Cevdet Peker
Department of Obstetrics and Gynecology, Faculty of Veterinary Medicine, Aydin Adnan Menderes University, Aydin, Turkey
6 shared publications - Mehmet Köse
Steril enjektör eppendorf tüpü santrifüj kanül alkol kan alma tüpü holder pamuk mikropipet
5 shared publications - Mehmet Osman Atli
Harran Üniversitesi, Veteriner Fakültesi
5 shared publications - Cevdet Peker
Aydin Adnan Menderes University, Faculty of Veterinary Medicine, Department of Obstetrics and Gynecology, Aydin, Turkey
2 shared publications - Faruk Bozkaya
Department of Genetics, Faculty of Veterinary Medicine, Harran University, Sanliurfa, Turkey
2 shared publications - Güneş Erdoğan
ADNAN MENDERES ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 87 (10)
Systemic oxidative stress, selected nonenzymatic exogenous and endogenous antioxidants, and hematologic and biochemical alterations in bitches with pyometra
Objective: To evaluate oxidative stress biomarkers (malondialdehyde [MDA] and total oxidant status [TOS]), selected nonenzymatic endogenous (glutathione [GSH], albumin, and bilirubin), and, for the first time, exogenous (ascorbic acid, α-tocopherol, β-carotene, and retinol) antioxidants together with hematobiochemical alterations in canine pyometra. Methods: 33 bitches were classified into pyometra (n = 17) or control (16) groups based on clinical and hematological evaluations. Ascorbic acid was measured by the phosphotungstate method; GSH, MDA, β-carotene, and retinol spectrophotometrically; α-tocopherol by ELISA; and TOS by a colorimetric assay. Hematobiochemical variables were analyzed using automated analyzers. Results: Bitches with pyometra had higher MDA and TOS than controls (36.30 ± 13.95 µmol/L vs 24.61 ± 4.80 µmol/L and 27.78 ± 15.51 µmol H 2 O 2 Eq/L vs 13.13 ± 1.84 µmol H 2 O 2 Eq/L; Hedges’ g = 1.08 and 1.27, respectively). Glutathione tended to increase in pyometra (12.04 ± 10.80 nmol/g Hb vs 6.40 ± 2.97 nmol/g Hb; Hedges’ g = 0.68), whereas the other antioxidants were similar between groups. Pyometra was also associated with leukocytosis, neutrophilia, monocytosis, decreased erythrocyte counts and Hct, and increased ALP, ALT, and cholesterol. Conclusions: Canine pyometra is accompanied by systemic oxidative stress and hematobiochemical alterations. However, circulating nonenzymatic antioxidants remained largely unchanged, suggesting complex antioxidant regulation rather than simple depletion. Increased GSH may reflect a thiol-based compensatory response to increased oxidative burden. Clinical Relevance: Nonenzymatic antioxidant regulation in canine pyometra may be more complex than simple depletion. Further studies incorporating disease-severity stratification and tissue-level assessments of both enzymatic and nonenzymatic antioxidants are warranted.
- 1 October 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 87 (10)
Open AccessSystemic oxidative stress, selected nonenzymatic exogenous and endogenous antioxidants, and hematologic and biochemical alterations in bitches with pyometra
Objective: To evaluate oxidative stress biomarkers (malondialdehyde [MDA] and total oxidant status [TOS]), selected nonenzymatic endogenous (glutathione [GSH], albumin, and bilirubin), and, for the first time, exogenous (ascorbic acid, α-tocopherol, β-carotene, and retinol) antioxidants together with hematobiochemical alterations in canine pyometra. Methods: 33 bitches were classified into pyometra (n = 17) or control (16) groups based on clinical and hematological evaluations. Ascorbic acid was measured by the phosphotungstate method; GSH, MDA, β-carotene, and retinol spectrophotometrically; α-tocopherol by ELISA; and TOS by a colorimetric assay. Hematobiochemical variables were analyzed using automated analyzers. Results: Bitches with pyometra had higher MDA and TOS than controls (36.30 ± 13.95 µmol/L vs 24.61 ± 4.80 µmol/L and 27.78 ± 15.51 µmol H 2 O 2 Eq/L vs 13.13 ± 1.84 µmol H 2 O 2 Eq/L; Hedges’ g = 1.08 and 1.27, respectively). Glutathione tended to increase in pyometra (12.04 ± 10.80 nmol/g Hb vs 6.40 ± 2.97 nmol/g Hb; Hedges’ g = 0.68), whereas the other antioxidants were similar between groups. Pyometra was also associated with leukocytosis, neutrophilia, monocytosis, decreased erythrocyte counts and Hct, and increased ALP, ALT, and cholesterol. Conclusions: Canine pyometra is accompanied by systemic oxidative stress and hematobiochemical alterations. However, circulating nonenzymatic antioxidants remained largely unchanged, suggesting complex antioxidant regulation rather than simple depletion. Increased GSH may reflect a thiol-based compensatory response to increased oxidative burden. Clinical Relevance: Nonenzymatic antioxidant regulation in canine pyometra may be more complex than simple depletion. Further studies incorporating disease-severity stratification and tissue-level assessments of both enzymatic and nonenzymatic antioxidants are warranted.
- Open Access
- 12 September 2025
- Published by Academician Publishing
- p. 355-357
Vücut Sıcaklığı Ölçme ve Değerlendirme
- 12 September 2025
- Published by Academician Publishing
- p. 355-357
Open AccessVücut Sıcaklığı Ölçme ve Değerlendirme
- Open Access
- 30 April 2025
- Published by Mehmet Akif Ersoy Universitesi Veteriner Fakultesi Dergisi in Mediterranean Veterinary Journal
- Vol. 10 (1) , 458-464
The influence of fetal sex and litter size on pregnancy-associated glycoprotein concentration at the end of the embryonic period in Hasak ewes
In sheep flocks, reproductive efficiency is a fundamental factor for economic profitability and a direct result of reproductive management. The management of pregnant ewes involves the diagnosis of pregnancy and the determination of the number of conceptions in utero to enable breeders to make informed decisions for the future management of the flock. The aim of this study was to investigate whether the concentration of pregnancy-associated glycoprotein (PAG) in plasma on day 35 of pregnancy can be used to predict the number and sex of conceptions in Hasak ewes. For this purpose, a total of 75 pregnant Hasak ewes aged 2-7 years kept under identical conditions were randomly selected. The pregnancy status and number of conceptions of the ewes were determined on day 35 after mating using a transrectal ultrasound technique with a 7.5 MHz linear probe. Immediately after pregnancy diagnosis, blood samples were taken from the jugular vein of all selected ewes and the plasma samples were separated. After a healthy pregnancy and lambing, the ewes were divided into five groups based on the number and sex of lambs born: singleton male lambing ewes (SM group, n=27), singleton female lambing ewes (SF group, n=27), twin male lambing ewes (TM group, n=8), twin female lambing ewes (TF group, n=7), one male and one female lambing ewes (TMF group, n=6). Plasma PAG concentrations were measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit. Data were analysed using an independent samples t-test and one-way ANOVA. The results showed that the number and sex of lambs born had no significant effect on plasma PAG concentrations measured on day 35 of pregnancy (p>0.05). In conclusion, plasma PAG concentration on day 35 of pregnancy is not a reliable predictor of the number or sex of lambs born in Hasak ewes.
- 30 April 2025
- Published by Mehmet Akif Ersoy Universitesi Veteriner Fakultesi Dergisi in Mediterranean Veterinary Journal
- Vol. 10 (1) , 458-464
Open AccessThe influence of fetal sex and litter size on pregnancy-associated glycoprotein concentration at the end of the embryonic period in Hasak ewes
In sheep flocks, reproductive efficiency is a fundamental factor for economic profitability and a direct result of reproductive management. The management of pregnant ewes involves the diagnosis of pregnancy and the determination of the number of conceptions in utero to enable breeders to make informed decisions for the future management of the flock. The aim of this study was to investigate whether the concentration of pregnancy-associated glycoprotein (PAG) in plasma on day 35 of pregnancy can be used to predict the number and sex of conceptions in Hasak ewes. For this purpose, a total of 75 pregnant Hasak ewes aged 2-7 years kept under identical conditions were randomly selected. The pregnancy status and number of conceptions of the ewes were determined on day 35 after mating using a transrectal ultrasound technique with a 7.5 MHz linear probe. Immediately after pregnancy diagnosis, blood samples were taken from the jugular vein of all selected ewes and the plasma samples were separated. After a healthy pregnancy and lambing, the ewes were divided into five groups based on the number and sex of lambs born: singleton male lambing ewes (SM group, n=27), singleton female lambing ewes (SF group, n=27), twin male lambing ewes (TM group, n=8), twin female lambing ewes (TF group, n=7), one male and one female lambing ewes (TMF group, n=6). Plasma PAG concentrations were measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit. Data were analysed using an independent samples t-test and one-way ANOVA. The results showed that the number and sex of lambs born had no significant effect on plasma PAG concentrations measured on day 35 of pregnancy (p>0.05). In conclusion, plasma PAG concentration on day 35 of pregnancy is not a reliable predictor of the number or sex of lambs born in Hasak ewes.
- Open Access
- 24 September 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (3) , 1-9
Effect of Intramammary Hypochlorous Acid Administration on Subclinical Mastitis in Dairy Cows
Subclinical mastitis is a significant issue in dairy farming due to its impact on milk production and quality, leading to economic losses despite the absence of visible symptoms. The present study aimed to investigate the potential use of intramammary hypochlorous acid (HOCl) treatment as a viable substitute to antibiotics for the treatment of subclinical mastitis (SCM) in dairy cows. A total of 232 Holstein–Friesian dairy cows with 928 udder quarters were subjected to the California Mastitis Test (CMT) to identify the SCM. The results indicated that 141 cows had SCM in at least one udder quarter, with a rate of 60.78% in the herd. Among these cows, 259 udder quarters showed varying degrees of CMT–positive. Before the treatment, somatic cell counts (SCC) were determined, and bacterial cultures were performed on randomly selected 74 CMT–positive udder quarters. The HOCl was administered intramammary to these quarters for 5 days immediately after milking. The CMT, SCC, and bacterial culture were repeated on the 3rd and 5th days of the treatment. An increase in SCC was observed on the 3rd and 5th day of the treatment compared to before treatment (P<0.001). The bacterial growth reduced from 64.86% before treatment to 49.95% on the 3rd day and 22.97% on the 5th day of the treatment. Staphylococcus aureus was the most prevalent bacterium before the treatment. On the 3rd day of the treatment, bacterial growth rate, particularly in Candida spp., decreased compared to before the treatment. However, on the 5th day of the treatment, S. aureus and the combination of S. aureus with Candida spp. continued to show high growth rates. In conclusion, this study underscores that HOCl is a potential alternative to antibiotics for treating SCM in dairy cows. Further research covering both clinical and subclinical mastitis is recommended, along with studies aiming to prolong the presence of HOCl in the udder, determine its ideal dose, and increase its impact on more cells.
- 24 September 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (3) , 1-9
Open AccessEffect of Intramammary Hypochlorous Acid Administration on Subclinical Mastitis in Dairy Cows
Subclinical mastitis is a significant issue in dairy farming due to its impact on milk production and quality, leading to economic losses despite the absence of visible symptoms. The present study aimed to investigate the potential use of intramammary hypochlorous acid (HOCl) treatment as a viable substitute to antibiotics for the treatment of subclinical mastitis (SCM) in dairy cows. A total of 232 Holstein–Friesian dairy cows with 928 udder quarters were subjected to the California Mastitis Test (CMT) to identify the SCM. The results indicated that 141 cows had SCM in at least one udder quarter, with a rate of 60.78% in the herd. Among these cows, 259 udder quarters showed varying degrees of CMT–positive. Before the treatment, somatic cell counts (SCC) were determined, and bacterial cultures were performed on randomly selected 74 CMT–positive udder quarters. The HOCl was administered intramammary to these quarters for 5 days immediately after milking. The CMT, SCC, and bacterial culture were repeated on the 3rd and 5th days of the treatment. An increase in SCC was observed on the 3rd and 5th day of the treatment compared to before treatment (P<0.001). The bacterial growth reduced from 64.86% before treatment to 49.95% on the 3rd day and 22.97% on the 5th day of the treatment. Staphylococcus aureus was the most prevalent bacterium before the treatment. On the 3rd day of the treatment, bacterial growth rate, particularly in Candida spp., decreased compared to before the treatment. However, on the 5th day of the treatment, S. aureus and the combination of S. aureus with Candida spp. continued to show high growth rates. In conclusion, this study underscores that HOCl is a potential alternative to antibiotics for treating SCM in dairy cows. Further research covering both clinical and subclinical mastitis is recommended, along with studies aiming to prolong the presence of HOCl in the udder, determine its ideal dose, and increase its impact on more cells.
- 2 February 2024
- Published by Elsevier in Theriogenology
- Vol. 218, 153-162
Altered luteal expression patterns of genomic and non-genomic progesterone receptors in bitches at different reproductive states
- 2 February 2024
- Published by Elsevier in Theriogenology
- Vol. 218, 153-162
Altered luteal expression patterns of genomic and non-genomic progesterone receptors in bitches at different reproductive states
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Animal Reproduction
- Vol. 21 (1) , e20230115
Expression of circulating oar-miR-485-5p and oar-miR-493-5p during the estrous cycle and early pregnancy in ovine plasma
In the current study, we aimed to assess the expression levels of two circulating microRNAs (miRNA) (oar-miR-485-5p and oar-miR-493-5p) in the ovine plasma during the peri-implantation. After mating, we collected the plasma samples from a total of 8 ewes on day 22 of pregnancy (P22; n = 4) and day 22 of the estrous cycle (C22; n=4). We used mature miRNA sequences for oar-miR-485-5p and oar-miR-493-5p out of one hundred fifty, which were retrieved from our microarray results of previous study. We showed that the miRNA expression of oar-miR-485-5p and oar-miR-493-5p were upregulated in P22 (P<0.05) when compared to C22. Those two miRNAs targeted 311 target genes in the peri-implantation period of pregnancy. Furthermore, we revealed 151 GO/pathway terms in biological process (BP) and 25 GO/pathway terms in molecular function (MF), while we demonstrated 13 GO/pathway terms in cellular component (CC). We revealed three hub genes as interleukin 2 (IL2), interleukin 18 (IL18), and C-X-C Motif Chemokine Ligand 10 (CXCL10). In conclusion, both miR-485-5p and oar-miR-493-5p have the potential to be a biomarker to understand peri-implantation of the ovine pregnancy in the aspect of pregnancy-reflected changes in maternal plasma.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Animal Reproduction
- Vol. 21 (1) , e20230115
Open AccessExpression of circulating oar-miR-485-5p and oar-miR-493-5p during the estrous cycle and early pregnancy in ovine plasma
In the current study, we aimed to assess the expression levels of two circulating microRNAs (miRNA) (oar-miR-485-5p and oar-miR-493-5p) in the ovine plasma during the peri-implantation. After mating, we collected the plasma samples from a total of 8 ewes on day 22 of pregnancy (P22; n = 4) and day 22 of the estrous cycle (C22; n=4). We used mature miRNA sequences for oar-miR-485-5p and oar-miR-493-5p out of one hundred fifty, which were retrieved from our microarray results of previous study. We showed that the miRNA expression of oar-miR-485-5p and oar-miR-493-5p were upregulated in P22 (P<0.05) when compared to C22. Those two miRNAs targeted 311 target genes in the peri-implantation period of pregnancy. Furthermore, we revealed 151 GO/pathway terms in biological process (BP) and 25 GO/pathway terms in molecular function (MF), while we demonstrated 13 GO/pathway terms in cellular component (CC). We revealed three hub genes as interleukin 2 (IL2), interleukin 18 (IL18), and C-X-C Motif Chemokine Ligand 10 (CXCL10). In conclusion, both miR-485-5p and oar-miR-493-5p have the potential to be a biomarker to understand peri-implantation of the ovine pregnancy in the aspect of pregnancy-reflected changes in maternal plasma.
- 26 December 2023
- Published by Adnan Menderes University in Animal Health Production and Hygiene
- Vol. 12 (2) , 36-41
The Effect of Human Chorionic Gonadotropin and Ketoprofen Applications on Pregnancy Rates in Dairy Cows After Artificial Insemination
The aim of the presented study is to investigate the effect of providing progesterone (P4) support for the formation and maintenance of pregnancy or suppressing the luteolysis mechanism during the maternal acceptance process on pregnancy rates. For this purpose, 96 Holstein cows, aged between 2 and 8 years, were synchronized using the Ovsynch protocol to align their estrous cycles. After artificial insemination, the cows were divided into four groups. The group receiving Human Chorionic Gonadotropn (hCG) on the 6th day after artificial insemination (H; n=20), the group receiving Ketoprofen on the evening of the 15th day and the morning of the 16th day after artificial insemination (K; n=24), the group receiving both hCG on the 6th day and Ketoprofen on the 15th day evening and 16th day morning after artificial insemination (HK; n=25), and the control group (C; n=27) that did not receive any post-insemination treatment were established. Pregnancy checks were conducted on the 30th, 45th, and 60th days through rectal and ultrasonographic (USG) examinations. According to the results of the pregnancy examinations, it was determined that 9 out of 20 cows (45.00%) in Group H, 10 out of 24 cows (41.67%) in Group K, 16 out of 25 cows (64.00%) in Group HK, and 12 out of 27 cows (44.44%) in Group C were pregnant. No statistically significant difference (P>0.05) was observed among the groups. Our results suggest that a multi-purpose treatment may be required to reduce pregnancy loss during the early pregnancy period in cows due to an approximately 20% increased pregnancy rate after administering hCG and Ketoprofen. However, further studies, especially involving more cows, are necessary to optimize and use these combined treatments and potentially increase pregnancy rates.
- 26 December 2023
- Published by Adnan Menderes University in Animal Health Production and Hygiene
- Vol. 12 (2) , 36-41
The Effect of Human Chorionic Gonadotropin and Ketoprofen Applications on Pregnancy Rates in Dairy Cows After Artificial Insemination
The aim of the presented study is to investigate the effect of providing progesterone (P4) support for the formation and maintenance of pregnancy or suppressing the luteolysis mechanism during the maternal acceptance process on pregnancy rates. For this purpose, 96 Holstein cows, aged between 2 and 8 years, were synchronized using the Ovsynch protocol to align their estrous cycles. After artificial insemination, the cows were divided into four groups. The group receiving Human Chorionic Gonadotropn (hCG) on the 6th day after artificial insemination (H; n=20), the group receiving Ketoprofen on the evening of the 15th day and the morning of the 16th day after artificial insemination (K; n=24), the group receiving both hCG on the 6th day and Ketoprofen on the 15th day evening and 16th day morning after artificial insemination (HK; n=25), and the control group (C; n=27) that did not receive any post-insemination treatment were established. Pregnancy checks were conducted on the 30th, 45th, and 60th days through rectal and ultrasonographic (USG) examinations. According to the results of the pregnancy examinations, it was determined that 9 out of 20 cows (45.00%) in Group H, 10 out of 24 cows (41.67%) in Group K, 16 out of 25 cows (64.00%) in Group HK, and 12 out of 27 cows (44.44%) in Group C were pregnant. No statistically significant difference (P>0.05) was observed among the groups. Our results suggest that a multi-purpose treatment may be required to reduce pregnancy loss during the early pregnancy period in cows due to an approximately 20% increased pregnancy rate after administering hCG and Ketoprofen. However, further studies, especially involving more cows, are necessary to optimize and use these combined treatments and potentially increase pregnancy rates.
- Open Access
- 2 August 2023
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 51
Early Maturation of Corpus Luteum in Rabbits - Effect of Sildenafil Citrate on Luteolytic Capacity in the Early Luteal Period
Background: Prostaglandin F2 alpha (PGF2α) binds to the specific receptor (PTGFR) on the corpus luteum (CL) in mammals, inducing regression of the CL structure (luteolysis) and initiating a new cycle. While PGF2α is effective only on mature CL, the immature CL structure (early luteal phase) resists PGF2α. In this study, sildenafil citrate, which is used to increase blood flow in the genital organs for treating specific pregnancy issues in women, was administered during the early luteal phase in a rabbit model to test the hypothesis of enhancing blood flow to the CL, thereby promoting earlier maturation and enabling a response to PGF2α. Materials, Methods & Results: The study was conducted in 2 sub-studies: clinical and molecular. A large number of rabbits were initially included in the sub-studies to ensure a sufficient number of pseudo-pregnant rabbits. Ovulation in rabbits was induced with buserelin acetate and was considered as day 0 of the study. The sub-studies were continued with rabbits whose pseudo-pregnancies were confirmed according to progesterone (P4) results. As a result, the studies were continued with a total of 41 pseudo-pregnant New Zealand female rabbits, 21 of which were included in the clinical sub-study and 20 in the molecular sub-study. In both sub-studies, on day 3 of the luteal period, rabbits in the treatment group received 5 mg/kg sildenafil citrate and all rabbits received a single dose of exogenous PGF2α on day 4 to induce luteolysis. In the clinical sub-study, echotexture and intraovarian blood flow changes in the ovaries were determined by ultrasonography (USG) examination. In the molecular sub-study, the expression changes of Hypoxia Inducible Factor 1 Alpha (HIF1A) and Vascular Endothelial Growth Factor (VEGF) related to angiogenesis, Steroidogenic Acute Regulatory Protein (StAR) related to P4 metabolism, Prostaglandin-Endoperoxide Synthase 2 (PTGS2) related to prostaglandin (PG) mechanism and 15-Hydroxyprostaglandin Dehydrogenase (HPGD) genes at mRNA level were determined using Real Time Polymerase Chain Reaction (RT-PCR) in CL tissues obtained with ovariohysterectomy (OVH) at 1 and 12 h after PGF2α injection. In addition, blood samples were collected for determine P4 levels from all rabbits. In the clinical sub-study; there was no difference between the groups in mean gray values (MGV), whereas there was a significant decrease in both pulsatile index (PI) and resistance index (RI) values at 40 min after PGF2α injection (P < 0.05). In the molecular sub-study, it was determined that sildenafil citrate had no significant effect (P > 0.05) on the expression levels 1 and 12 h after PGF2α injection. According to the results of the molecular sub-study, no significant effect of sildenafil citrate on the mRNA expression levels in the investigated genes was detected (P > 0.05). However, within each group, differences were found according to OVH time after PGF2α injection. It was observed that PTGS2 and HPGD mRNA expressions decreased at the 12th h compared to the 1st h, while HIF1A expression increased (P < 0.05). Discussion: According to the results obtained from clinical and molecular sub-studies, it was determined that a single dose of sildenafil citrate (5 mg/kg) applied on the 3rd day of the luteal period did not contribute to the maturation process of the CL, did not increase blood flow, and was insufficient to break the resistance of the CL against PGF2α applied on the 4th day of the luteal period. However, a significant decrease in the PI value at the 40th min after PGF2α injection suggests that sildenafil citrate has a supportive effect, and that this decrease is also seen in the RI value, suggesting that its effect is insufficient against the vasoconstrictive effect of PGF2α. Keywords: sildenafil citrate, PGF2 alpha, corpus luteum, early luteal stage, rabbit.
- 2 August 2023
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 51
Open AccessEarly Maturation of Corpus Luteum in Rabbits - Effect of Sildenafil Citrate on Luteolytic Capacity in the Early Luteal Period
Background: Prostaglandin F2 alpha (PGF2α) binds to the specific receptor (PTGFR) on the corpus luteum (CL) in mammals, inducing regression of the CL structure (luteolysis) and initiating a new cycle. While PGF2α is effective only on mature CL, the immature CL structure (early luteal phase) resists PGF2α. In this study, sildenafil citrate, which is used to increase blood flow in the genital organs for treating specific pregnancy issues in women, was administered during the early luteal phase in a rabbit model to test the hypothesis of enhancing blood flow to the CL, thereby promoting earlier maturation and enabling a response to PGF2α. Materials, Methods & Results: The study was conducted in 2 sub-studies: clinical and molecular. A large number of rabbits were initially included in the sub-studies to ensure a sufficient number of pseudo-pregnant rabbits. Ovulation in rabbits was induced with buserelin acetate and was considered as day 0 of the study. The sub-studies were continued with rabbits whose pseudo-pregnancies were confirmed according to progesterone (P4) results. As a result, the studies were continued with a total of 41 pseudo-pregnant New Zealand female rabbits, 21 of which were included in the clinical sub-study and 20 in the molecular sub-study. In both sub-studies, on day 3 of the luteal period, rabbits in the treatment group received 5 mg/kg sildenafil citrate and all rabbits received a single dose of exogenous PGF2α on day 4 to induce luteolysis. In the clinical sub-study, echotexture and intraovarian blood flow changes in the ovaries were determined by ultrasonography (USG) examination. In the molecular sub-study, the expression changes of Hypoxia Inducible Factor 1 Alpha (HIF1A) and Vascular Endothelial Growth Factor (VEGF) related to angiogenesis, Steroidogenic Acute Regulatory Protein (StAR) related to P4 metabolism, Prostaglandin-Endoperoxide Synthase 2 (PTGS2) related to prostaglandin (PG) mechanism and 15-Hydroxyprostaglandin Dehydrogenase (HPGD) genes at mRNA level were determined using Real Time Polymerase Chain Reaction (RT-PCR) in CL tissues obtained with ovariohysterectomy (OVH) at 1 and 12 h after PGF2α injection. In addition, blood samples were collected for determine P4 levels from all rabbits. In the clinical sub-study; there was no difference between the groups in mean gray values (MGV), whereas there was a significant decrease in both pulsatile index (PI) and resistance index (RI) values at 40 min after PGF2α injection (P < 0.05). In the molecular sub-study, it was determined that sildenafil citrate had no significant effect (P > 0.05) on the expression levels 1 and 12 h after PGF2α injection. According to the results of the molecular sub-study, no significant effect of sildenafil citrate on the mRNA expression levels in the investigated genes was detected (P > 0.05). However, within each group, differences were found according to OVH time after PGF2α injection. It was observed that PTGS2 and HPGD mRNA expressions decreased at the 12th h compared to the 1st h, while HIF1A expression increased (P < 0.05). Discussion: According to the results obtained from clinical and molecular sub-studies, it was determined that a single dose of sildenafil citrate (5 mg/kg) applied on the 3rd day of the luteal period did not contribute to the maturation process of the CL, did not increase blood flow, and was insufficient to break the resistance of the CL against PGF2α applied on the 4th day of the luteal period. However, a significant decrease in the PI value at the 40th min after PGF2α injection suggests that sildenafil citrate has a supportive effect, and that this decrease is also seen in the RI value, suggesting that its effect is insufficient against the vasoconstrictive effect of PGF2α. Keywords: sildenafil citrate, PGF2 alpha, corpus luteum, early luteal stage, rabbit.
- Open Access
- 7 June 2023
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIII (2) , 1-6
Plasma profile of Pregnancy Associated Glycoproteins during Postpartum period in Konya Merino ewes lambing single and twin
En este estudio, se investigó el Perfil Plasmático de las Glicoproteínas asociadas a la preñez (PAGs) después del parto en ovejas Konya Merino utilizando un kit de prueba de preñez utilizado en el ganado vacuno. Se utilizó un total de 16 ovejas Konya Merino como material. Se establecieron cuatro grupos de ovejas que parieron a un cordero macho (grupo SM, n=4), una cordera hembra (grupo SF, n=4), corderos mellizos machos (grupo TM, n=4) o corderas mellizas hembras (grupo TF, n=4). Se tomaron muestras de plasma sanguíneo en los días 0 (día del parto), 3; 7; 10; 14 y luego semanalmente hasta el día 35. Todas las muestras se analizaron utilizando un kit de prueba de preñez bovino para detectar el nivel de PAGs. Se determinó que existe una fuerte correlación negativa entre el nivel de PAGs en la sangre periférica y los días después del parto (r2=0,969; P<0,01). Sin embargo, no se encontró ninguna relación entre el nivel de PAGs y el género del cordero o el tipo de parto. En conclusión, el nivel plasmático de PAGs disminuyó rápidamente en ovejas Konya Merino independientemente del género y tipo de parto del cordero. Además, los resultados mostraron que el perfil plasmático de PAGs después del parto en ovejas Konya Merino se puede monitorear con un kit comercial de prueba de preñez bovino basado en ELISA, y los resultados de la prueba se pueden utilizar en decisiones y evaluaciones basadas en los niveles de las moléculas de PAGs.
- 7 June 2023
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIII (2) , 1-6
Open AccessPlasma profile of Pregnancy Associated Glycoproteins during Postpartum period in Konya Merino ewes lambing single and twin
En este estudio, se investigó el Perfil Plasmático de las Glicoproteínas asociadas a la preñez (PAGs) después del parto en ovejas Konya Merino utilizando un kit de prueba de preñez utilizado en el ganado vacuno. Se utilizó un total de 16 ovejas Konya Merino como material. Se establecieron cuatro grupos de ovejas que parieron a un cordero macho (grupo SM, n=4), una cordera hembra (grupo SF, n=4), corderos mellizos machos (grupo TM, n=4) o corderas mellizas hembras (grupo TF, n=4). Se tomaron muestras de plasma sanguíneo en los días 0 (día del parto), 3; 7; 10; 14 y luego semanalmente hasta el día 35. Todas las muestras se analizaron utilizando un kit de prueba de preñez bovino para detectar el nivel de PAGs. Se determinó que existe una fuerte correlación negativa entre el nivel de PAGs en la sangre periférica y los días después del parto (r2=0,969; P<0,01). Sin embargo, no se encontró ninguna relación entre el nivel de PAGs y el género del cordero o el tipo de parto. En conclusión, el nivel plasmático de PAGs disminuyó rápidamente en ovejas Konya Merino independientemente del género y tipo de parto del cordero. Además, los resultados mostraron que el perfil plasmático de PAGs después del parto en ovejas Konya Merino se puede monitorear con un kit comercial de prueba de preñez bovino basado en ELISA, y los resultados de la prueba se pueden utilizar en decisiones y evaluaciones basadas en los niveles de las moléculas de PAGs.